Protagenic Therapeutics, Inc.
PTIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34 | $60 | $97 | $286 |
| - Cash | $2 | $1 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $32 | $59 | $97 | $286 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$4 | -$3 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$5 | -$4 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.13 | -1.15 | -0.82 | -1.24 |
| % Growth | 1.7% | -40.2% | 33.9% | – |
| Operating Cash Flow | -$4 | -$4 | -$2 | -$3 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$4 | -$4 | -$2 | -$3 |